A qualitative study of patient experiences with telemedicine opioid use disorder treatment during COVID-19 [0.03%]
新冠肺炎疫情期间美国患者远程治疗阿片类物质使用障碍的体验及影响因素——定性研究
Rachel Lockard,Kelsey C Priest,Jessica Gregg et al.
Rachel Lockard et al.
Background: The drug-related overdose crisis worsened during the COVID-19 pandemic. Recent drug policy changes to increase access to medications for opioid use disorder (MOUD) during COVID-19 shifted some outpatient MOUD treatment into virt...
Cannabis dispensary online marketing practices in response to COVID-19 lockdowns [0.03%]
新冠疫情封锁期间的大麻分店线上营销策略
Pamela M Ling,Eric Crosbie,Louisa M Holmes et al.
Pamela M Ling et al.
Background: The COVID-19 pandemic has been accompanied by increases in cannabis consumption, which might relate to dispensary marketing activities. As part of an ongoing project monitoring cannabis dispensary websites in Northern California...
Associations between elevated depressive symptoms and substance use, prescription opioid misuse, overdose history, pain, and general health among community pharmacy patients prescribed opioids [0.03%]
社区药房中处方阿片类药物患者的抑郁症状与物质使用、处方阿片类药物误用、过量史、疼痛和总体健康状况之间的关联
Jennifer L Brown,Gerald Cochran,M Aryana Bryan et al.
Jennifer L Brown et al.
Background: Individuals with pain prescribed opioids experience high rates of comorbid depression. The aim of this study was to characterize pain, substance use, and health status as a function of depressive symptom level in individuals fil...
Alcohol consumption and alcohol home delivery laws during the COVID-19 pandemic [0.03%]
新冠疫情时期的酒精消耗与酒精送货上门法规
Elyse R Grossman,Sara E Benjamin-Neelon,Susan Sonnenschein
Elyse R Grossman
Background: Alcohol consumption in the U.S. is a public health problem that has been exacerbated by the COVID-19 pandemic. Relatedly, many states have responded to COVID-19 by relaxing their alcohol laws, making it possible for adults to ha...
Alcohol use disorder pharmacotherapy and treatment in primary care (ADaPT-PC) trial: Impact on identified barriers to implementation [0.03%]
酒精使用障碍药物治疗与初级保健中的治疗（ADaPT-PC）试验：识别实施障碍的影响
Hildi J Hagedorn,Jennifer P Wisdom,Heather Gerould et al.
Hildi J Hagedorn et al.
Background: A minority of individuals meeting diagnostic criteria for alcohol use disorders (AUD) receive any type of formal treatment. Developing options for AUD treatment within primary care settings is imperative to increase treatment ac...
Perceptions of peer and parental attitudes toward substance use and actual adolescent substance use: The impact of adolescent-confidant relationships [0.03%]
同伴和父母对物质使用的态度及实际的青少年物质使用情况：基于青少年倾诉关系的影响
Megan E Marziali,Natalie S Levy,Silvia S Martins
Megan E Marziali
Objective: While peer influence is a well-documented risk factor for adolescent substance use, it remains unclear whether peer or parental attitudes have greater impact, and if this relationship is moderated by having a confidant and the re...
Real-world study of multiple naloxone administrations for opioid overdose reversal among emergency medical service providers [0.03%]
基于急救医务人员的阿片类药物过量复苏用纳洛酮给药真实世界研究
Randa Abdelal,A Raja Banerjee,Suzanne Carlberg-Racich et al.
Randa Abdelal et al.
Background: The increasing rates of highly potent, illicit synthetic opioids (i.e., fentanyl) in the US is exacerbating the ongoing opioid epidemic. Multiple naloxone administrations (MNA) may be required to successfully reverse opioid over...
Adam Soberay,Sharon Levy,Francis Cheung et al.
Adam Soberay et al.
Background: Screening for substance use within pediatric primary care provides a unique opportunity to identify adolescents in need of intervention. Methods: This study analyzed screening data collected across 13 Federally Qualified Health ...
Sociodemographic differences in quality of treatment to Medicaid enrollees receiving buprenorphine [0.03%]
面向美泰克斯登记接受布施丙醇治疗患者的治疗质量的社情差异性分析
Rachel K Landis,Jonathan S Levin,Brendan Saloner et al.
Rachel K Landis et al.
Background: Buprenorphine is a key medication to treat opioid use disorder, but little is known about how treatment quality varies across sociodemographic groups. Objective: We examined measures of treatment quality and explored variation b...
Trends in buprenorphine-waivered providers in Medicaid expansion and non-expansion states by their public listing status [0.03%]
扩张和非扩张州的麻萨诸塞药签发医生趋势及其公开列表情况
Maria X Sanmartin,Mir M Ali,Debra S Dwyer
Maria X Sanmartin
Background: The federal government has made several efforts to increase access to buprenorphine for the treatment of opioid use disorder (OUD). However, patients continue to face challenges in access to treatment for OUD. Objectives: This s...